Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

Nephro-Urology Monthly

homeHome
play_arrowCurrent IssuelistAll Issuesformat_indent_increaseIn PresssearchSearchcheck_circleAccepted Manuscripts
settingsInstructions
bookmarkJournal InformationgroupsBoards and CommitteesshareIndexing and Listing SourcesbalancePublication Ethics and Malpractice StatementemailSupportassignment_indReviewer and AE Registration FormphoneContact Usshow_chartJournal Metricszoom_inOpen Peer Review (OPR)
format_list_bulletedAPC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. The Frequency and Causes of Erythropoietin-Resistant Anemia in Children Under Dialysis

- Naseri M. , et al.

2. Evaluation of hepcidin-25/erythroferrone ratio as a potential biomarker for iron utility and erythropoiesis responsiveness to erythropoiesis-stimulating therapy in comparison to immature erythrocyte/reticulocyte parameters in hemodialysis patients

- Bakr S. , et al.

3. Evaluation of Erythropoietin Stimulating Agent’s Responsiveness and Associated Factors in Hemodialysis Patients with Anemia

- Alzubaidy S.A. , et al.

4. Managing Anemia across the Stages of Kidney Disease in Those Hyporesponsive to Erythropoiesis-Stimulating Agents

- Weir M.R. , et al.

5. Erythropoietin resistance in patients with chronic kidney disease: Current perspectives

- Santos E.J.F. , et al.

6. Anemia and the use of antihypertensive medications in hemodialysis patients: multicenter retrospective observational study

- Stepanova N. , et al.

7. Melatonin improves erythropoietin hyporesponsiveness via suppression of inflammation

- Hameed E.N. , et al.